Grifols S A : appoints Miguel Louzan Chief Digital Information Officer

September 19, 2023

Grifols appoints Miguel Louzan Chief Digital Information Officer

Print this news Download the press release

• In his newly created role, Mr. Louzan will drive the company's digital transformation and information technology priorities, ensuring the companywide integration of advanced capabilities to help accelerate business growth and lead cybersecurity
• Mr. Louzan is an international pharmaceutical information technology executive with nearly 30 years of experience leading digital and data transformation

Barcelona, Spain, Sept. 19, 2023 - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global leader in plasma medicines with more than 110 years contributing to improve the health and well-being of people, today announced that it has named Miguel Louzan Chief Digital Information Officer (CDIO).

Mr. Louzan is Grifols' first CDIO, a responsibility that recognizes the convergence of digital technologies and the broader category of information systems. His mandate is to accelerate the company's use of digital platforms, data science and new technologies to transform and strengthen critical business activities such as relationships with plasma donors and customers as well as manufacturing operations, the development of new therapeutics and cybersecurity. Accordingly Mr. Louzan will focus on greater application of artificial intelligence, point-of-contact technologies and other automation tools that will help Grifols drive its strategic growth plans effectively and efficiently.

He will also look to add to the world-class partnerships Grifols is leveraging as part of its ongoing efforts to make technology a differentiating company attribute. Most recently, Grifols forged a collaboration with Google Cloud to speed up the development of new therapeutics in its flagship Biopharma business unit.

A veteran of the global pharmaceutical and healthcare industries, Mr. Louzan has almost 30 years' experience building and executing world-class digital and data transformation initiatives for drug and medical device companies and manufacturers.

Before Grifols, Mr. Louzan was managing director for technology transformation at a major private equity firm, where he advised leading companies on their digital and technology strategies. Before this he was the chief information officer for LifeScan, a company specializing in diabetes care. Mr. Louzan also held senior IT management positions with UCB Pharma, dedicated to treating neurological and immunological diseases, and Boston Scientific, a maker of medical devices. He was also chief information officer for SWM, a manufacturer of paper and fiber as well as resin products.

"Miguel has the experience and track record to make Grifols a clear leader in our application of digital and new technologies to help drive efficient growth and support our mission of enhancing the health and well-being of people," said Victor Grifols Deu, Grifols Chief Operating Officer.

"I'm thrilled to join a globally revered healthcare leader such as Grifols, where there are great opportunities to upscale the company's digital and technology platforms to create value for the entire organization and its stakeholders," said Mr. Louzan.

Mr. Louzan holds a bachelor's degree in accounting and finance from Cooremans University, in Brussels, and an MBA from Emory University's Goizueta Business School.